Garrett Garborcauskas

ORCID: 0000-0003-0316-461X · 3 papers in corpus
other 2025
Use of Continuous Oral Drospirenone for Menstrual Suppression in Adolescents
The Journal of adolescent health : official publication of the Society for Adolescent Medicine ·doi:10.1016/j.jadohealth.2024.09.004

PURPOSE: To describe experiences of adolescents taking continuous drospirenone (DRSP-C) oral contraceptives, without placebo, for menstrual suppression, including breakthrough bleeding and other side-effects. METHODS: This was a retrospect…

article 2025
Use of the Drospirenone-Only Contraceptive Pill in Adolescents With Endometriosis
·doi:10.1097/ogx.0000000000001408

(Abstracted from J Pediatr Adolesc Gynecol 2024;37(4):402–406 One of the leading causes of dysmenorrhea in adolescents is endometriosis, or the growth of endometrial tissue outside the uterus. Endometriosis significantly impacts quality of …

article 2024
Use of the Drospirenone-Only Contraceptive Pill in Adolescents with Endometriosis
Journal of Pediatric and Adolescent Gynecology ·doi:10.1016/j.jpag.2024.02.003

STUDY OBJECTIVE: To evaluate the efficacy and tolerability of a progestin-only pill containing 4 mg drospirenone (DRSP) as a hormonal therapy for the management of endometriosis-associated symptoms in adolescents and young adults. DESIGN: …